{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:06:41Z","timestamp":1774940801318,"version":"3.50.1"},"reference-count":171,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as Non-alcoholic fatty liver disease (NAFLD) describes a diverse array of liver conditions linked to disrupted metabolic processes, ranging from hepatic steatosis and steatohepatitis to fibrosis, cirrhosis, and ultimately hepatocellular carcinoma (HCC). Currently, MASLD has progressively become a primary contributor to chronic liver disease globally. Due to its multifactorial etiology and varied clinical presentations, MASLD remains challenging in terms of accurate diagnosis and effective management. Accumulating evidence underscores the pivotal involvement of the interleukin-33 (IL-33)\/suppression of tumorigenicity 2 (ST2) signaling pathway in critical aspects of MASLD pathophysiology, such as metabolic balance, oxidative stress response, intestinal barrier integrity, microbiota dynamics, inflammatory processes, hepatic fibrosis, and tumor development. IL-33 plays an exceptionally complex and central role in the pathophysiological processes of MASLD, and current evidence suggests that its actions may appear contradictory. Therefore, this review systematically integrates molecular insights into IL-33 biology and elucidates the regulatory networks underpinning IL-33\/ST2 interactions, emphasizing their distinct roles at different MASLD stages. Furthermore, it is particularly noteworthy that IL-33 expression varies dynamically throughout disease progression. Additionally, the potential clinical utility of IL-33 as both a biomarker for early diagnosis and a therapeutic target is examined. By synthesizing fundamental and clinical research, this review aims to enhance the understanding of immunometabolic mechanisms involved in MASLD, thereby offering theoretical support and identifying future directions for personalized diagnostic and therapeutic approaches. The current research is largely limited to animal model studies, with a lack of longitudinal cohort studies in humans, which creates challenges for translational medicine.<\/jats:p>","DOI":"10.3389\/fmed.2026.1762478","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:34:36Z","timestamp":1774935276000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Critical role of interleukin-33 in pathogenesis and progression of metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Chunmei","family":"Ran","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Affiliated Renhe Hospital of China Three Gorges University","place":["Yichang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Renhe Hospital of China Three Gorges University","place":["Yichang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Science, China Three Gorges University","place":["Yichang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chibing","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Affiliated Renhe Hospital of China Three Gorges University","place":["Yichang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1080\/10408398.2021.1992748","article-title":"Effects and mechanisms of tea on obesity","volume":"63","author":"Xu","year":"2023","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1016\/j.cgh.2021.02.030","article-title":"Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults","volume":"20","author":"Liu","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/s0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and Meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3350\/cmh.2022.0239","article-title":"Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach","volume":"28","author":"Le","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"Liver EAftSot, diabetes EAftSo, obesity EAftSo","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: revisited after a decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.4254\/wjh.v16.i10.1142","article-title":"Pathogenesis and research progress of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"16","author":"Shan","year":"2024","journal-title":"World J Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"980","DOI":"10.4254\/wjh.v16.i7.980","article-title":"Interleukin-mediated therapies in liver diseases and comorbidity effects","volume":"16","author":"Bouare","year":"2024","journal-title":"World J Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4254\/wjh.v16.i2.140","article-title":"Interleukins in liver disease treatment","volume":"16","author":"Yang","year":"2024","journal-title":"World J Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an Interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.3390\/ijms241713504","article-title":"A deep view of the biological property of Interleukin-33 and its dysfunction in the gut","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0002-9440(10)63631-0","article-title":"Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial Venules","volume":"163","author":"Baekkevold","year":"2003","journal-title":"Am J Pathol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1172\/JCI65570","article-title":"Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease","volume":"123","author":"Byers","year":"2013","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1073\/pnas.1115884109","article-title":"IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G","volume":"109","author":"Lefrancais","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1073\/pnas.1424236112","article-title":"Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33","volume":"112","author":"Chen","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"8327","DOI":"10.1038\/ncomms9327","article-title":"Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation","volume":"6","author":"Cohen","year":"2015","journal-title":"Nat Commun"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/ni.2341","article-title":"F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation","volume":"13","author":"Zhao","year":"2012","journal-title":"Nat Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"eabq3362","DOI":"10.1126\/scisignal.abq3362","article-title":"SUMOylated IL-33 in the nucleus stabilizes the transcription factor IRF1 in hepatocellular carcinoma cells to promote immune escape","volume":"16","author":"Wang","year":"2023","journal-title":"Sci Signal"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.4049\/jimmunol.1102832","article-title":"IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs","volume":"188","author":"Bartemes","year":"2012","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.4049\/jimmunol.1000730","article-title":"IL-33 exacerbates eosinophil-mediated airway inflammation","volume":"185","author":"Stolarski","year":"2010","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.4049\/jimmunol.1400481","article-title":"IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R\/ST2+ regulatory T cells","volume":"193","author":"Matta","year":"2014","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2015.02.011","article-title":"Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection","volume":"42","author":"Kearley","year":"2015","journal-title":"Immunity"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12619","article-title":"Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family","volume":"281","author":"Cayrol","year":"2018","journal-title":"Immunol Rev"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"107847","DOI":"10.1016\/j.pharmthera.2021.107847","article-title":"The central role of IL-33\/IL-1RL1 pathway in asthma: from pathogenesis to intervention","volume":"225","author":"Saikumar Jayalatha","year":"2021","journal-title":"Pharmacol Ther"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1177\/15353702231198075","article-title":"Roles of IL-33 in the pathogenesis of cardiac disorders","volume":"248","author":"Jiang","year":"2023","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"kyac006","DOI":"10.1093\/discim\/kyac006","article-title":"The role of interleukin-33 in organ fibrosis","volume":"1","author":"Di Carmine","year":"2022","journal-title":"Discov Immunol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3390\/ijms24031991","article-title":"Unveiling IL-33\/ST2 pathway unbalance in cardiac remodeling due to obesity in Zucker fatty rats","volume":"24","author":"Sitzia","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3390\/medicina57040315","article-title":"IL-33 in mental disorders","volume":"57","author":"Pandolfo","year":"2021","journal-title":"Med Kaunas"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3390\/cells12111481","article-title":"Interleukin-33: friend or foe in gastrointestinal tract cancers?","volume":"12","author":"Pisani","year":"2023","journal-title":"Cells"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1111\/j.1582-4934.2009.00801.x","article-title":"Interleukin-33 overexpression is associated with liver fibrosis in mice and humans","volume":"14","author":"Marvie","year":"2010","journal-title":"J Cell Mol Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/cmi.2016.62","article-title":"Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells","volume":"14","author":"Weiskirchen","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"33649","DOI":"10.18632\/oncotarget.9259","article-title":"IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1172\/JCI73742","article-title":"Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation","volume":"124","author":"Li","year":"2014","journal-title":"J Clin Invest"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e18468","DOI":"10.1111\/jcmm.18468","article-title":"Comprehensively analysis of IL33 in hepatocellular carcinoma prognosis, immune microenvironment and biological role","volume":"28","author":"Wei","year":"2024","journal-title":"J Cell Mol Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.3390\/ijms19092732","article-title":"NLRP3 Inflammasome and IL-33: novel players in sterile liver inflammation","volume":"19","author":"Neumann","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.34172\/mejdd.2022.263","article-title":"Association between melatonin value and interleukins1B, \u221218, and \u221233 levels in patients with different stages of non-alcoholic fatty liver disease","volume":"14","author":"Sohrabi","year":"2022","journal-title":"Middle East J Dig Dis"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/HEP.0000000000000985","article-title":"Intestinal IL-33 promotes microbiota-derived trimethylamine N -oxide synthesis and drives metabolic dysfunction-associated steatotic liver disease progression by exerting dual regulation on HIF-1alpha","volume":"82","author":"Hai","year":"2025","journal-title":"Hepatology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2119\/molmed.2014.00178","article-title":"Galectin-3 ablation enhances liver steatosis, but attenuates inflammation and IL-33-dependent fibrosis in obesogenic mouse model of nonalcoholic steatohepatitis","volume":"21","author":"Jeftic","year":"2015","journal-title":"Mol Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"48563","DOI":"10.18632\/oncotarget.18335","article-title":"Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis","volume":"8","author":"Vasseur","year":"2017","journal-title":"Oncotarget"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12967-024-05180-0","article-title":"IL-33 regulates adipogenesis via Wnt\/beta-catenin\/PPAR-gamma signaling pathway in preadipocytes","volume":"22","author":"Xu","year":"2024","journal-title":"J Transl Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3390\/ijms21113933","article-title":"The role of pro-inflammatory and regulatory signaling by IL-33 in the brain and liver: a focused systematic review of mouse and human data and risk of Bias assessment of the literature","volume":"21","author":"Zharichenko","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"100149","DOI":"10.1016\/j.metop.2021.100149","article-title":"Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)","volume":"12","author":"Zarghamravanbakhsh","year":"2021","journal-title":"Metabol Open"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4291\/wjgp.v7.i2.211","article-title":"Insulin resistance in development and progression of nonalcoholic fatty liver disease","volume":"7","author":"Alam","year":"2016","journal-title":"World J Gastrointest Pathophysiol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/hepr.12656","article-title":"The independent predictors of non-alcoholic steatohepatitis and its individual histological features: insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment","volume":"46","author":"Ballestri","year":"2016","journal-title":"Hepatol Res"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.4254\/wjh.v16.i8.1120","article-title":"Correlation between non-alcoholic fatty liver disease and metabolic parameters in persons with newly diagnosed type 2 diabetes mellitus","volume":"16","author":"Mukherjee","year":"2024","journal-title":"World J Hepatol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ajg.2016.178","article-title":"Metabolically healthy obesity and the development of nonalcoholic fatty liver disease","volume":"111","author":"Chang","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/ijms25020699","article-title":"Circulating Interleukins-33 and -37 and their associations with metabolic syndrome in Arab adults","volume":"25","author":"Amer","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"156080","DOI":"10.1016\/j.cyto.2022.156080","article-title":"Interleukin-33 inhibits glucose uptake in human adipocytes and its expression in adipose tissue is elevated in insulin resistance and type 2 diabetes","volume":"161","author":"Pereira","year":"2023","journal-title":"Cytokine"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.immuni.2017.10.015","article-title":"Interleukin-33-activated islet-resident innate lymphoid cells promote insulin secretion through myeloid cell retinoic acid production","volume":"47","author":"Dalmas","year":"2017","journal-title":"Immunity"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/abbs\/gmaa045","article-title":"The essential function of IL-33 in metabolic regulation","volume":"52","author":"Li","year":"2020","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.1038\/s41467-022-33171-6","article-title":"Liver group 2 innate lymphoid cells regulate blood glucose levels through IL-13 signaling and suppression of gluconeogenesis","volume":"13","author":"Fujimoto","year":"2022","journal-title":"Nat Commun"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.3389\/fimmu.2018.03026","article-title":"Inhibiting glycolysis and ATP production attenuates IL-33-mediated mast cell function and peritonitis","volume":"9","author":"Caslin","year":"2018","journal-title":"Front Immunol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fimmu.2019.00127","article-title":"Deficiency in IL-33\/ST2 Axis reshapes mitochondrial metabolism in lipopolysaccharide-stimulated macrophages","volume":"10","author":"Xu","year":"2019","journal-title":"Front Immunol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.4049\/jimmunol.1600651","article-title":"Lactic acid suppresses IL-33-mediated mast cell inflammatory responses via hypoxia-inducible factor-1alpha-dependent miR-155 suppression","volume":"197","author":"Abebayehu","year":"2016","journal-title":"J Immunol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"900826","DOI":"10.3389\/fimmu.2022.900826","article-title":"Interleukin-33: metabolic checkpoints, metabolic processes, and epigenetic regulation in immune cells","volume":"13","author":"Lin","year":"2022","journal-title":"Front Immunol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"eaay6191","DOI":"10.1126\/sciadv.aay6191","article-title":"The obesity-induced adipokine sST2 exacerbates adipose T(reg) and ILC2 depletion and promotes insulin resistance","volume":"6","author":"Zhao","year":"2020","journal-title":"Sci Adv"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.4049\/jimmunol.1500020","article-title":"IL-33 reverses an obesity-induced deficit in visceral adipose tissue ST2+ T regulatory cells and ameliorates adipose tissue inflammation and insulin resistance","volume":"194","author":"Han","year":"2015","journal-title":"J Immunol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.4049\/jimmunol.1701256","article-title":"Modulation of the IL-33\/IL-13 axis in obesity by IL-13Ralpha2","volume":"200","author":"Duffen","year":"2018","journal-title":"J Immunol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat Med"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41590-019-0439-5","article-title":"Fat IL-33 sources","volume":"20","author":"Dempsey","year":"2019","journal-title":"Nat Immunol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00011-019-01214-2","article-title":"IL-33 in obesity: where do we go from here?","volume":"68","author":"De Oliveira","year":"2019","journal-title":"Inflamm Res"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12967-021-02711-x","article-title":"Circulating levels of IL-33 are elevated by obesity and positively correlated with metabolic disorders in Chinese adults","volume":"19","author":"Tang","year":"2021","journal-title":"J Transl Med"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/ijo.2012.118","article-title":"Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue","volume":"37","author":"Zeyda","year":"2013","journal-title":"Int J Obes"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nri2692","article-title":"Disease-associated functions of IL-33: the new kid in the IL-1 family","volume":"10","author":"Liew","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature14115","article-title":"Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity","volume":"519","author":"Brestoff","year":"2015","journal-title":"Nature"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cell.2014.12.011","article-title":"Activated type 2 innate lymphoid cells regulate beige fat biogenesis","volume":"160","author":"Lee","year":"2015","journal-title":"Cell"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/circresaha.110.218867","article-title":"Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice","volume":"107","author":"Miller","year":"2010","journal-title":"Circ Res"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/cvr\/cvy166","article-title":"Conflicting vascular and metabolic impact of the IL-33\/sST2 axis","volume":"114","author":"Altara","year":"2018","journal-title":"Cardiovasc Res"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.4049\/jimmunol.1000520","article-title":"IL-33 reduces macrophage foam cell formation","volume":"185","author":"McLaren","year":"2010","journal-title":"J Immunol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3390\/nu16081195","article-title":"IL-33 reduces saturated fatty acid accumulation in mouse atherosclerotic foci","volume":"16","author":"Hosomi","year":"2024","journal-title":"Nutrients"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J Exp Med"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"e0142141","DOI":"10.1371\/journal.pone.0142141","article-title":"Elevated circulating interleukin 33 levels in stable renal transplant recipients at high risk for cardiovascular events","volume":"10","author":"Mansell","year":"2015","journal-title":"PLoS One"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1089\/ars.2016.6776","article-title":"Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis","volume":"26","author":"Spahis","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/antiox10020174","article-title":"Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy","volume":"10","author":"Arroyave-Ospina","year":"2021","journal-title":"Antioxidants"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.26355\/eurrev_201803_14593","article-title":"IL-33 induced inflammation exacerbated the development of chronic obstructive pulmonary disease through oxidative stress","volume":"22","author":"Zou","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.3390\/antiox11122343","article-title":"Interleukin-33 induces neutrophil extracellular trap (NET) formation and macrophage necroptosis via enhancing oxidative stress and secretion of proatherogenic factors in advanced atherosclerosis","volume":"11","author":"Tembhre","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"107584","DOI":"10.1016\/j.pharmthera.2020.107584","article-title":"Targeting the human microbiome and its metabolite TMAO in cardiovascular prevention and therapy","volume":"213","author":"Dannenberg","year":"2020","journal-title":"Pharmacol Ther"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"2331460","DOI":"10.1080\/19490976.2024.2331460","article-title":"Breaking the barriers: the role of gut homeostasis in metabolic-associated Steatotic liver disease (MASLD)","volume":"16","author":"Benede-Ubieto","year":"2024","journal-title":"Gut Microbes"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1136\/gutjnl-2011-301785","article-title":"Neutralisation of the interleukin-33\/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice","volume":"62","author":"Sedhom","year":"2013","journal-title":"Gut"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41385-021-00386-7","article-title":"Interleukin-33 signaling exacerbates experimental infectious colitis by enhancing gut permeability and inhibiting protective Th17 immunity","volume":"14","author":"Palmieri","year":"2021","journal-title":"Mucosal Immunol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/ijms24010623","article-title":"Molecular mechanisms underlying IL-33-mediated inflammation in inflammatory bowel disease","volume":"24","author":"Aggeletopoulou","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/ni.2916","article-title":"A gut reaction to IL-9","volume":"15","author":"Hufford","year":"2014","journal-title":"Nat Immunol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jcmgh.2019.02.006","article-title":"Interleukin-33 promotes REG3gamma expression in intestinal epithelial cells and regulates gut microbiota","volume":"8","author":"Xiao","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41598-017-00840-2","article-title":"Interleukin-33 regulates intestinal inflammation by modulating macrophages in inflammatory bowel disease","volume":"7","author":"Seo","year":"2017","journal-title":"Sci Rep"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"10762","DOI":"10.1073\/pnas.1509070112","article-title":"IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions","volume":"112","author":"Monticelli","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1126\/science.1133715","article-title":"Amphiregulin, a TH2 cytokine enhancing resistance to nematodes","volume":"314","author":"Zaiss","year":"2006","journal-title":"Science"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41374-019-0329-3","article-title":"Interleukin-33 delays recovery of mucosal inflammation via downregulation of homeostatic ABCG5\/8 in the colon","volume":"100","author":"Mishima","year":"2020","journal-title":"Lab Investig"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"E9362","DOI":"10.1073\/pnas.1803613115","article-title":"IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair","volume":"115","author":"Lopetuso","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.immuni.2020.10.014","article-title":"Interleukin-33 promotes serotonin release from Enterochromaffin cells for intestinal homeostasis","volume":"54","author":"Chen","year":"2021","journal-title":"Immunity"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jdermsci.2016.10.008","article-title":"Nuclear expression of IL-33 in epidermal keratinocytes promotes wound healing in mice","volume":"85","author":"Oshio","year":"2017","journal-title":"J Dermatol Sci"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"106849","DOI":"10.4254\/wjh.v17.i6.106849","article-title":"Gut microbiota in non-alcoholic fatty liver disease: pathophysiology, diagnosis, and therapeutics","volume":"17","author":"Pandey","year":"2025","journal-title":"World J Hepatol"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"eabl7209","DOI":"10.1126\/sciimmunol.abl7209","article-title":"Gasdermin D-mediated release of IL-33 from senescent hepatic stellate cells promotes obesity-associated hepatocellular carcinoma","volume":"7","author":"Yamagishi","year":"2022","journal-title":"Sci Immunol"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-022-05380-y","article-title":"Inulin fibre promotes microbiota-derived bile acids and type 2 inflammation","volume":"611","author":"Arifuzzaman","year":"2022","journal-title":"Nature"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s13071-022-05490-6","article-title":"Interleukin-33 deficiency prevents biliary injuries and repairments caused by Clonorchis sinensis via restraining type 2 cytokines","volume":"15","author":"Yan","year":"2022","journal-title":"Parasit Vectors"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1172\/JCI88625","article-title":"IL-33 regulates the IgA-microbiota axis to restrain IL-1alpha-dependent colitis and tumorigenesis","volume":"126","author":"Malik","year":"2016","journal-title":"J Clin Invest"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/ibd.22900","article-title":"IL-33 attenuates development and perpetuation of chronic intestinal inflammation","volume":"18","author":"Grobeta","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fonc.2018.00561","article-title":"Contribution of IL-33 to the pathogenesis of colorectal Cancer","volume":"8","author":"Cui","year":"2018","journal-title":"Front Oncol"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00109-024-02477-x","article-title":"WNT2B high-expressed fibroblasts induce the fibrosis of IBD by promoting NK cells secreting IL-33","volume":"102","author":"Cheng","year":"2024","journal-title":"J Mol Med (Berl)"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/jci57132","article-title":"Inflammatory links between obesity and metabolic disease","volume":"121","author":"Lumeng","year":"2011","journal-title":"J Clin Invest"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/s0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \"hits\"?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/j.jss.2010.04.004","article-title":"Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure","volume":"163","author":"Roth","year":"2010","journal-title":"J Surg Res"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/jir.2011.0109","article-title":"Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B","volume":"32","author":"Wang","year":"2012","journal-title":"J Interf Cytokine Res"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"819636","DOI":"10.1155\/2012\/819636","article-title":"Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C","volume":"2012","author":"Wang","year":"2012","journal-title":"Mediat Inflamm"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1523\/eneuro.0147-17.2017","article-title":"Behavioral changes in mice lacking Interleukin-33","volume":"4","author":"Dohi","year":"2017","journal-title":"eNeuro"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1136\/ard.2009.122655","article-title":"IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy","volume":"69","author":"Verri","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4049\/jimmunol.1103564","article-title":"IL-33 priming regulates multiple steps of the neutrophil-mediated anti-Candida albicans response by modulating TLR and dectin-1 signals","volume":"189","author":"Le","year":"2012","journal-title":"J Immunol"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1476-9255-8-22","article-title":"Role of IL-33 in inflammation and disease","volume":"8","author":"Miller","year":"2011","journal-title":"J Inflamm (Lond)"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4049\/jimmunol.1600418","article-title":"A Proinflammatory role of type 2 innate lymphoid cells in murine immune-mediated hepatitis","volume":"198","author":"Neumann","year":"2017","journal-title":"J Immunol"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00109-012-0938-4","article-title":"Blockade of IL-33 ameliorates con A-induced hepatic injury by reducing NKT cell activation and IFN-\u03b3 production in mice","volume":"90","author":"Chen","year":"2012","journal-title":"J Mol Med (Berl)"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijcard.2018.05.056","article-title":"The IL-33\/ST2 pathway, inflammation and atherosclerosis: trigger and target?","volume":"267","author":"Aimo","year":"2018","journal-title":"Int J Cardiol"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver \u2014 from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/cmi.2016.63","article-title":"Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells","volume":"15","author":"Tan","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"5314213","DOI":"10.1155\/2017\/5314213","article-title":"IL-33-ST2 Axis in liver disease: progression and challenge","volume":"2017","author":"Sun","year":"2017","journal-title":"Mediat Inflamm"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"9930902","DOI":"10.1155\/2023\/9930902","article-title":"Comparison of inflammatory cytokine levels in hepatic and jugular veins of patients with cirrhosis","volume":"2023","author":"Kaps","year":"2023","journal-title":"Mediat Inflamm"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.molmed.2018.03.005","article-title":"IL-1 family cytokine pathways underlying NAFLD: towards new treatment strategies","volume":"24","author":"Mirea","year":"2018","journal-title":"Trends Mol Med"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jcmgh.2023.12.011","article-title":"Th2 cell activation in chronic liver disease is driven by local IL33 and contributes to IL13-dependent Fibrogenesis","volume":"17","author":"Reissing","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jcmgh.2024.01.004","article-title":"The interleukin 33\u2013T helper 2 cell Axis promotes human liver fibrosis","volume":"17","author":"Lurje","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3109\/14653249.2011.637668","article-title":"Reduction of galectin-3 expression and liver fibrosis after cell therapy in a mouse model of cirrhosis","volume":"14","author":"De Oliveira","year":"2012","journal-title":"Cytotherapy"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"e75361","DOI":"10.1371\/journal.pone.0075361","article-title":"Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease","volume":"8","author":"Traber","year":"2013","journal-title":"PLoS One"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s41598-020-57985-w","article-title":"Hepatic ILC2 activity is regulated by liver inflammation-induced cytokines and effector CD4(+) T cells","volume":"10","author":"Steinmann","year":"2020","journal-title":"Sci Rep"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis","volume":"39","author":"McHedlidze","year":"2013","journal-title":"Immunity"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"781012","DOI":"10.3389\/fphys.2021.781012","article-title":"IL-33 as a critical cytokine for inflammation and fibrosis in inflammatory bowel diseases and pancreatitis","volume":"12","author":"Kurimoto","year":"2021","journal-title":"Front Physiol"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jhep.2019.09.033","article-title":"PSMP\/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target","volume":"72","author":"She","year":"2020","journal-title":"J Hepatol"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular Cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"key":"ref134","first-page":"1722","article-title":"Nonalcoholic steatohepatitis is associated with a higher risk of advanced colorectal neoplasm","author":"Cho","year":"2019"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12967-020-02661-w","article-title":"Exogenous interleukin-33 promotes hepatocellular carcinoma growth by remodelling the tumour microenvironment","volume":"18","author":"Wang","year":"2020","journal-title":"J Transl Med"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pathogens11010057","article-title":"Elevated levels of IL-33, IL-17 and IL-25 indicate the progression from chronicity to hepatocellular carcinoma in hepatitis C virus patients","volume":"11","author":"Askoura","year":"2022","journal-title":"Pathogens"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3892\/ol.2016.4622","article-title":"Role of IL-33 expression in oncogenesis and development of human hepatocellular carcinoma","volume":"12","author":"Yang","year":"2016","journal-title":"Oncol Lett"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1136\/gutjnl-2021-325288","article-title":"The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma","volume":"71","author":"Heinrich","year":"2022","journal-title":"Gut"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1186\/s12885-023-11179-5","article-title":"The association of serum IL-33\/ST2 expression with hepatocellular carcinoma","volume":"23","author":"Pan","year":"2023","journal-title":"BMC Cancer"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-020-2015-4","article-title":"ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity","volume":"579","author":"Moral","year":"2020","journal-title":"Nature"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbrc.2019.08.058","article-title":"<article-title update=\"added\">endogenous IL-33 exerts CD8+ T cell antitumor responses overcoming pro-tumor effects by regulatory T cells in a colon carcinoma model","volume":"518","author":"Xia","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41586-024-08426-5","article-title":"IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer","volume":"638","author":"Amisaki","year":"2025","journal-title":"Nature"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/cancers11111664","article-title":"IL-33 promotes CD11b\/CD18-mediated adhesion of eosinophils to Cancer cells and synapse-polarized degranulation leading to tumor cell killing","volume":"11","author":"Andreone","year":"2019","journal-title":"Cancers (Basel)"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.4049\/jimmunol.1800627","article-title":"IL-33 released in the liver inhibits tumor growth via promotion of CD4+ and CD8+ T cell responses in hepatocellular carcinoma","volume":"201","author":"Jin","year":"2018","journal-title":"J Immunol"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1002\/hep.27728","article-title":"Tumor-infiltrating, interleukin-33-producing effector-memory CD8(+) T cells in resected hepatocellular carcinoma prolong patient survival","volume":"61","author":"Brunner","year":"2015","journal-title":"Hepatology"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1177\/030006051204000504","article-title":"Detection of interleukin-33 in serum and carcinoma tissue from patients with hepatocellular carcinoma and its clinical implications","volume":"40","author":"Zhang","year":"2012","journal-title":"J Int Med Res"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1053\/j.gastro.2020.09.040","article-title":"Interleukin 33 triggers early eosinophil-dependent events leading to metaplasia in a chronic model of gastritis-prone mice","volume":"160","author":"De Salvo","year":"2021","journal-title":"Gastroenterology"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1136\/gutjnl-2016-312779","article-title":"A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach","volume":"67","author":"Petersen","year":"2018","journal-title":"Gut"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"e106151","DOI":"10.15252\/embj.2020106151","article-title":"Nuclear IL-33\/SMAD signaling axis promotes cancer development in chronic inflammation","volume":"40","author":"Park","year":"2021","journal-title":"EMBO J"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/s12276-024-01249-4","article-title":"IL-33 and IL-33-derived DC-based tumor immunotherapy","volume":"56","author":"Kang","year":"2024","journal-title":"Exp Mol Med"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1016\/j.celrep.2019.10.120","article-title":"IL-33 signaling alters regulatory T cell diversity in support of tumor development","volume":"29","author":"Li","year":"2019","journal-title":"Cell Rep"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1038\/s41467-019-10676-1","article-title":"IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization","volume":"10","author":"Eissmann","year":"2019","journal-title":"Nat Commun"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"E2487","DOI":"10.1073\/pnas.1422445112","article-title":"IL-33 activates tumor stroma to promote intestinal polyposis","volume":"112","author":"Maywald","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"e18142","DOI":"10.7717\/peerj.18142","article-title":"Assessment of combined serum sST2 and AFP levels in the diagnosis of hepatocellular carcinoma","volume":"12","author":"Tang","year":"2024","journal-title":"PeerJ"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.amjms.2019.07.008","article-title":"Interleukin-33\/ST2 signaling promotes hepatocellular carcinoma cell Stemness expansion through activating c-Jun N-terminal kinase pathway","volume":"358","author":"Zhao","year":"2019","journal-title":"Am J Med Sci"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13046-019-1052-z","article-title":"Tobacco smoke induced hepatic cancer stem cell-like properties through IL-33\/p38 pathway","volume":"38","author":"Xie","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1002\/hep4.2017","article-title":"Acute portal hypertension using portal vein ligation abrogates TRAIL expression of liver-resident NK cells","volume":"6","author":"Imaoka","year":"2022","journal-title":"Hepatol Commun"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/ijc.28481","article-title":"Interleukin-33\/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells","volume":"134","author":"Jovanovic","year":"2014","journal-title":"Int J Cancer"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"2918517","DOI":"10.1155\/2020\/2918517","article-title":"CD44, IL-33, and ST2 gene polymorphisms on hepatocellular carcinoma susceptibility in the Chinese population","volume":"2020","author":"Pan","year":"2020","journal-title":"Biomed Res Int"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.cyto.2018.03.036","article-title":"Genetic variants in IL-33\/ST2 pathway with the susceptibility to hepatocellular carcinoma in a Chinese population","volume":"118","author":"Wei","year":"2019","journal-title":"Cytokine"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.4049\/jimmunol.181.7.4656","article-title":"Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model","volume":"181","author":"Shimamura","year":"2008","journal-title":"J Immunol"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1183\/23120541.00718-2023","article-title":"AERIFY-1\/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD","volume":"10","author":"Rabe","year":"2024","journal-title":"ERJ Open Res"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.jaci.2022.08.015","article-title":"Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis","volume":"150","author":"Maurer","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4314\/ahs.v18i2.9","article-title":"An eight cytokine signature identified from peripheral blood serves as a fingerprint for hepatocellular cancer diagnosis","volume":"18","author":"Shen","year":"2018","journal-title":"Afr Health Sci"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1593\/tlo.12418","article-title":"High serum levels of the Interleukin-33 receptor soluble ST2 as a negative prognostic factor in hepatocellular carcinoma","volume":"6","author":"Bergis","year":"2013","journal-title":"Transl Oncol"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"5360","DOI":"10.1038\/s41467-025-60894-z","article-title":"Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens","volume":"16","author":"Huang","year":"2025","journal-title":"Nat Commun"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/S2213-2600(21)00167-3","article-title":"Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial","volume":"9","author":"Rabe","year":"2021","journal-title":"Lancet Respir Med"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"eadu3759","DOI":"10.1126\/scitranslmed.adu3759","article-title":"The IL-33 and IL-4Ralpha blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma","volume":"17","author":"Asrat","year":"2025","journal-title":"Sci Transl Med"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"9825","DOI":"10.1038\/s41598-023-36642-y","article-title":"Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE\/EGFR to reduce inflammation and epithelial dysfunction","volume":"13","author":"England","year":"2023","journal-title":"Sci Rep"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/cpt.3147","article-title":"A randomized phase I study of the anti-Interleukin-33 antibody Tozorakimab in healthy adults and patients with chronic obstructive pulmonary disease","volume":"115","author":"Reid","year":"2024","journal-title":"Clin Pharmacol Ther"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1762478\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:34:39Z","timestamp":1774935279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1762478\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":171,"alternative-id":["10.3389\/fmed.2026.1762478"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1762478","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"article-number":"1762478"}}